Officer plans to sell ~$969K of Regeneron Pharmaceuticals
Planned, from payLoading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director exercised or converted 400 REGN derivative securities
Traded Sep 2, 2026 · Filed Sep 3, 2026
- 400
- Shares · @ $719.37
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Sep 2, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Sep 3, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001992352-26-000007
